Autologous transplantation: Purging and the impact of minimal residual disease

Hematology/Oncology Clinics of North America

Volumn 13, Issue 5, 1999, Pages 969-986

  Vescio, R ^a   Berenson, J ^a  

^a Bldg 500   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

AUTOGRAFT; AUTOTRANSPLANTATION; BONE MARROW PURGING; CANCER SURVIVAL; CELL KILLING; DRUG EFFECT; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOMA; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK BENEFIT ANALYSIS; THROMBOCYTE TRANSFUSION;

EID: 0032834413     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70105-2     Document Type: Article

References (45)

1. K.C. Anderson B.A. Barut J. Ritz Monoclonal antibody-purged autologous bone marrow transplantation therapy for multiple myeloma Blood 77 1991 712 720
2. F.R. Appelbaum The Gulati/Romero/Ciavarella article reviewed Oncology (Huntingt) 8 1994 24 30
3. J. Atta H. Martin J. Bruecher Residual leukemia and immunomagnetic bead purging in patients with bcr-abl–positive acute lymphoblastic leukemia Bone Marrow Transplant 18 1996 541 548
4. M. Attal J.L. Harousseau A.M. Stoppa A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma patients N Engl J Med 335 1996 91
5. M.H. Bakkus C. Heirman I. Van Riet Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation Blood 80 1992 2326 2335
6. B. Barlogie S. Jagannath D.H. Vesole Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma Blood 89 1997 789 793
7. J.M. Bird S. Luger P. Mangan 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement Bone Marrow Transplant 18 1996 309 313
8. M.K. Brenner D.R. Rill R.C. Moen Gene-marking to trace origin of relapse after autologous bone-marrow transplantation Lancet 341 1993 85 86
9. A. Butturini R.P. Gale Clinical models of autotransplants in chronic myelogenous leukemia Leuk Lymphoma 11 Suppl 1 1993 255 257
10. H. Cavé J. van der Werff ten Bosch S. Suciu Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia N Engl J Med 339 1998 591 598
11. J. Ciudad J.F. San Miguel M.C. Lopez-Berges Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia J Clin Oncol 16 1998 3774 3781
12. P. Corradini M. Astolfi C. Cherasco Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high-dose chemotherapy and peripheral blood progenitor cell autografts Blood 89 1997 724 731
13. D. Cunningham R. Powles J. Malpas A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: Long-term follow-up results Br J Haematol 102 1998 495 502
14. L. Douay Negative selection and protection of normal progenitor cells for autografting Bone Marrow Transplant 22 1998 423 430
15. M.A. Gertz T.E. Witzig A.A. Pineda Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation Bone Marrow Transplant 19 1997 337 342
16. N.C. Gorin P. Aegerter B. Auvert Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: A European survey of the role of marrow purging Blood 75 1990 1606 1614
17. N.C. Gorin M. Labopin G. Meloni Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: Further evidence of the role of marrow purging by mafosfamide Leukemia 5 1991 896
18. J.G. Gribben Contemporary techniques for the detection of minimal residual disease J. Gribben The Role of Tumor Purging in Autologous Transplantation 1997 Discovery International Deerfield, IL
19. J.G. Gribben A.S. Freedman D. Neuberg Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma N Engl J Med 325 1991 1525 1533
20. B. Gruhn S. Hongeng H. Yi Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome Leukemia 12 1998 675 681
21. D. Gupta A. Bybee F. Cooke CD34+-selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: Tumor contamination and outcome Br J Haematol 104 1999 166 177
22. B.M. Leonard F. Hetu L. Busque Lymphoma cell burden in progenitor cell grafts measured by competitive polymerase chain reaction: Less than one log difference between bone marrow and peripheral blood sources Blood 91 1998 331 339
23. J.C. McCann R. Kanteti B. Shilepsky High degree of occult tumor contamination in bone marrow and peripheral blood stem cells of patients undergoing autologous transplantation for non-Hodgkin's lymphoma Biol Blood Marrow Transplant 2 1996 37 43
24. G. Meloni D. Diverio M. Vignetti Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: Prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RARα fusion gene Blood 90 1997 1321 1325
25. S. Mizuta A. Kohno M. Tanimoto Quantitative molecular analysis of the efficacy of ex vivo purging predicts clinical outcome after autologous BMT in patients with B-lineage acute lymphoblastic leukemia Blood 88 Suppl 1 1996 73a
26. T.J. Moss M. Cairo V.M. Santana Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation Blood 83 1994 3085 3089
27. D. Provan L. Bartlett-Pandite C. Zwicky Eradication of polymerase chain reaction-detectable chronic lymphocytic leukemia cells is associated with improved outcome after bone marrow transplantation Blood 88 1996 2228 2235
28. Q.M. Ralph M.J. Brisco D.E. Joshua Advancement of multiple myeloma from diagnosis through plateau phase to progression does not involve a new B-cell clone: Evidence from the Ig heavy chain gene Blood 82 1993 202 206
29. D.R. Rill V.M. Santana W.M. Roberts Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells Blood 84 1994 380 383
30. V. Rizzoli L. Mangoli C. Carlo-Stella Autologous bone marrow transplantation in acute myelogenous leukemia Leukemia 6 1992 1101 1106
31. A.M. Ross B.W. Cooper H.M. Lazarus Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques Blood 82 1993 2605 2610
32. S.D. Rowley R.J. Jones S. Piantadosi Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia Blood 74 1989 501 506
33. J.G. Sharp A. Kessinger S. Mann Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest J Clin Oncol 14 1996 214 219
34. D.S. Siegel S. Jagannath K.R. Desikan Feasibility of high dose chemotherapy with peripheral blood stem cell support for multiple myeloma patients over the age of 70 Blood 88 Suppl 1 1996 130a
35. J. Treleaven R. Powles S. Singhal Autografting with CD52 monoclonal antibody-purged marrow for acute lymphoblastic leukemia Blood 88 Suppl 1 1996 225a
36. G. Tricot Y. Gazitt T. Leemhuis Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma Blood 91 1998 4489 4495
37. J.J. van Dongen T. Seriu E.R. Panzer-Grumayer Prognostic value of minimal residual disease in acute lymphoblastic leukemia in childhood Lancet 352 1998 1731 1738
38. R.A. Vescio J. Cao C.H. Hong Myeloma Ig heavy chain V region sequences reveal prior antigeneic selection and marked somatic mutation but no intraclonal diversity J Immunol 155 1995 2487 2497
39. R.A. Vescio E.J. Han G.J. Schiller Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapharesis autografts Bone Marrow Transplant 18 1996 103 110
40. R. Vescio G. Schiller A.K. Stewart Multicenter phase III trial to evaluate CD34+ selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma Blood 93 1999 1858 1868
41. R.A. Vescio G.J. Schiller A.K. Stewart Quantitative assessment of myeloma peripheral blood and bone marrow tumor burden in patients undergoing autologous transplantation Blood 88 Suppl 1 1996 641a
42. R.A. Vescio A.K. Stewart O. Ballester Circulating multiple myeloma cell burden predicts disease relapse following autologous transplantation Blood 92 Suppl 1 1998 97a
43. C.D. Williams A.H. Goldstone R.M. Pearce Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: A case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry J Clinical Oncol 14 1996 2454 2464
44. T.E. Witzig M.A. Gertz A.A. Pineda Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma Br J Haematol 89 1995 640 642
45. C.S. Zwicky A.B. Maddocks N. Andersen Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation Blood 88 1996 3314 3322